LFA
NVAX icon

Level Financial Advisors’s Novavax NVAX Stock Holding History

Level Financial Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-78
Closed -$374 – 193
2023
Q4 		$374 Hold
78
– – ﹤0.01% 262
2023
Q3 		$565 Hold
78
– – ﹤0.01% 269
2023
Q2 		$580 Hold
78
– – ﹤0.01% 269
2023
Q1 		$541 Hold
78
– – ﹤0.01% 231
2022
Q4 		$1K Hold
78
– – ﹤0.01% 259
2022
Q3 		$1K Hold
78
– – ﹤0.01% 235
2022
Q2 		$4K Hold
78
– – ﹤0.01% 226
2022
Q1 		$6K Hold
78
– – ﹤0.01% 178
2021
Q4 		$11K Buy
+78
New +$13.4K 0.01% 172

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Level Financial Advisors's NVAX Position: Q1 2024 in Review

Level Financial Advisors sold out of Novavax (NVAX) in Q1 2024, closing a stake of 78 shares — an estimated $374 sold.

Level Financial Advisors first reported a position in NVAX in Q4 2021 and held it in 9 quarters. The position peaked at $11K in Q4 2021. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.

  • Level Financial Advisors reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
  • Level Financial Advisors sold 78 Novavax shares in Q1 2024, an estimated $374.
  • Level Financial Advisors first reported a position in Novavax in Q4 2021 and held it in 9 quarters.
  • Level Financial Advisors's Novavax position peaked at $11K in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.

Based on Level Financial Advisors's 13F filing for Q1 2024, filed 19 Apr 2024.